Review
doi: 10.1016/j.critrevonc.2015.03.008.
Epub 2015 Apr 15.
Management of metastatic pancreatic cancer: Current treatment options and potential new therapeutic targets
Affiliations
- PMID: 25921418
- DOI: 10.1016/j.critrevonc.2015.03.008
Item in Clipboard
Review
Management of metastatic pancreatic cancer: Current treatment options and potential new therapeutic targets
Crit Rev Oncol Hematol.
2015 Sep.
Abstract
Pancreatic ductal adenocarcinoma is a malignancy with a poor prognosis, with the majority of patients diagnosed with advanced disease on presentation. Treatment options remain limited with little progress over the last 40 years. This review will focus on the current management of metastatic pancreatic ductal adenocarcinoma, with a discussion of new and future treatment strategies based on an improved understanding of tumour biology and mechanisms of pathogenesis.
Keywords: FOLFIRINOX; Gemcitabine; Nab-paclitaxel; Nanoliposomal irinotecan; Pancreatic adenocarcinoma; Pancreatic cancer; Stroma.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Metastatic pancreatic ductal adenocarcinoma: diagnosis and treatment with a view to the future.Intern Med J. 2018 Jun;48(6):637-644. doi: 10.1111/imj.13810. Intern Med J. 2018. PMID: 29898269 Review.
-
FOLFIRINOX for locally advanced or metastatic pancreatic ductal adenocarcinoma: the Royal Marsden experience.Clin Colorectal Cancer. 2014 Dec;13(4):232-8. doi: 10.1016/j.clcc.2014.09.005. Epub 2014 Sep 21. Clin Colorectal Cancer. 2014. PMID: 25442814
-
Therapeutic Approaches for Metastatic Pancreatic Adenocarcinoma.Hematol Oncol Clin North Am. 2015 Aug;29(4):761-76. doi: 10.1016/j.hoc.2015.04.012. Epub 2015 Jun 9. Hematol Oncol Clin North Am. 2015. PMID: 26226909 Review.
-
Long-term outcome of patients with advanced pancreatic cancer treated with sequential chemotherapies before the era of modern combination therapy protocols.J Cancer Res Clin Oncol. 2019 Feb;145(2):445-455. doi: 10.1007/s00432-018-2789-z. Epub 2018 Nov 14. J Cancer Res Clin Oncol. 2019. PMID: 30430229
-
Pancreatic ductal adenocarcinoma: metastatic disease.Clin Transl Oncol. 2017 Dec;19(12):1423-1429. doi: 10.1007/s12094-017-1690-6. Epub 2017 Jun 16. Clin Transl Oncol. 2017. PMID: 28623515 Review.
Cited by
-
Pancreatic cancer presenting as colonic disease. A rare case report.Int J Surg Case Rep. 2018;44:4-7. doi: 10.1016/j.ijscr.2018.01.019. Epub 2018 Feb 9. Int J Surg Case Rep. 2018. PMID: 29454229 Free PMC article.
-
Rutin Promotes Pancreatic Cancer Cell Apoptosis by Upregulating miRNA-877-3p Expression.Molecules. 2022 Mar 31;27(7):2293. doi: 10.3390/molecules27072293. Molecules. 2022. PMID: 35408691 Free PMC article.
-
MiR-200a Suppresses the Proliferation and Metastasis in Pancreatic Ductal Adenocarcinoma through Downregulation of DEK Gene.Transl Oncol. 2016 Feb;9(1):25-31. doi: 10.1016/j.tranon.2015.11.005. Transl Oncol. 2016. PMID: 26947878 Free PMC article.
-
Liposomal irinotecan in gemcitabine-refractory metastatic pancreatic cancer: efficacy, safety and place in therapy.Ther Adv Med Oncol. 2017 Mar;9(3):159-170. doi: 10.1177/1758834016688816. Epub 2017 Mar 1. Ther Adv Med Oncol. 2017. PMID: 28344661 Free PMC article. Review.
-
Interleukin-15 stimulates natural killer cell-mediated killing of both human pancreatic cancer and stellate cells.Oncotarget. 2017 May 25;8(34):56968-56979. doi: 10.18632/oncotarget.18185. eCollection 2017 Aug 22. Oncotarget. 2017. PMID: 28915646 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
